Login
$SION
$3.12 +$0.00 (0.0%) After hours

Company Executives

Officer Age In this role 2025 pay Source
Michael Cloonan, M.B.A. Also a director
President & CEO
Title from the Form 4 dated Sep 17, 2026
55 Not stated $6,981,217
Elena Ridloff
Chief Financial Officer
46 Since 2021
5 years
$2,857,367
Jennifer Fitzpatrick
Chief Legal Officer
49 Since 2025
1 year
Not reported
Charlotte McKee
CMO and Head of R&D
Title from the Form 4 dated Sep 17, 2026
62 Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
10
serving now
Independent
9 of 10
stated in the proxy
Average tenure
3.9 years
from year joined
CEO also chairs the board
No
Paul Clancy, M.B.A.
Director Age On board Independent Committees Other public boards 2025 pay Source
Paul Clancy, M.B.A.
64 2022
4 years
Independent
Audit Committee Nominating and Corporate Governance Committee · Chair
Incyte Corporation $323,139
Michael Cloonan, M.B.A.
55 2021
5 years
Not independent None stated None stated Paid as CEO
H. Edward Fleming, Jr., M.D.
63 2024
2 years
Independent
Audit Committee
Upstream Bio, Inc. $283,039
Marcella Kuhlman Ruddy, M.D.
63 2025
1 year
Independent
Nominating and Corporate Governance Committee
Upstream Bio, Inc. $803,566
Peter A. Thompson, M.D.
66 2022
4 years
Independent
Nominating and Corporate Governance Committee
ARS Pharmaceuticals Inc. $279,889
Joanne Louise Viney, Ph.D.
60 2025
1 year
Independent
Compensation Committee · Chair
None stated $810,316
Bruce Booth, D.Phil.
52 2020
6 years
Independent
Compensation Committee
Kymera Therapeutics, Inc. $281,239
Lucian Iancovici, M.D.
44 2019
7 years
Independent
Compensation Committee
Rallybio Corporation Not stated
Joshua Resnick, M.D., M.B.A.
51 2019
7 years
Independent None stated PepGen Inc. $275,839
Laurie Stelzer, M.B.A.
58 2024
2 years
Independent
Audit Committee · Chair Compensation Committee
PMV Pharmaceuticals, Inc., MBX Biosciences, Inc. $299,639

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 27, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support